# Medallion Financial Corp: overview MFIN · Nasdaq · CIK 1000209 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/mfin.md) · [Financials](/companies/mfin/financials.md) · [Filings](/companies/mfin/filings.md) · [Insiders](/companies/mfin/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.37](/filings/0001193125-25-264655.md) | not reported | [0.50](/filings/0001193125-26-206358.md) | [0.46](/filings/0001193125-26-335042.md) | [0.32](/filings/0001193125-25-264655.md) | not reported | [0.20](/filings/0001193125-26-206358.md) | [0.31](/filings/0001193125-26-335042.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [2.17](/filings/0000950170-24-027942.md) | [1.83](/filings/0000950170-25-038693.md) | [2.37](/filings/0001193125-26-100121.md) | [1.52](/filings/0001193125-26-100121.md) | [1.78](/filings/0001193125-26-100121.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mfin/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $12.4m | 1,219,363 | | Added +111,398 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $7.4m | 722,282 | | Reduced −126,358 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $4.6m | 448,220 | | Added +35,036 | | [Uniplan Investment Counsel, Inc.](/funds/1520710.md) | 2026-06-30 | $4.1m | 397,330 | | Added +11,749 | | [SEI INVESTMENTS CO](/funds/350894.md) | 2026-06-30 | $2.6m | 250,080 | | Reduced −240,892 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $2.5m | 243,195 | | Reduced −5,316 | | [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $2.2m | 217,202 | | Added +30,056 | | [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $2.2m | 214,575 | | Unchanged | | [Connor, Clark & Lunn Investment Management Ltd.](/funds/1596800.md) | 2026-06-30 | $2.1m | 201,485 | | Reduced −11,338 | | [De Lisle Partners LLP](/funds/2011184.md) | 2026-06-30 | $2.0m | 198,711 | | Unchanged | ## Recent filings [All 1,045 filings](/companies/mfin/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-29 | 16:07 ET | [8-K](/filings/0001193125-26-437792.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-437792 | | 2026-10-21 | 16:05 ET | [8-K](/filings/0001193125-26-427818.md) | 7.01 Regulation FD disclosure | 0001193125-26-427818 | | 2026-10-19 | 16:30 ET | [8-K](/filings/0001140361-26-040112.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-040112 | | 2026-09-24 | 09:00 ET | [8-K](/filings/0001193125-26-400319.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-400319 | | 2026-09-22 | 16:22 ET | [8-K](/filings/0001193125-26-397961.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-397961 | | 2026-08-05 | 16:06 ET | [10-Q](/filings/0001193125-26-335042.md) | Quarterly report, period 2026-06-30 | 0001193125-26-335042 | | 2026-07-29 | 16:10 ET | [8-K](/filings/0001193125-26-323730.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-323730 | | 2026-06-26 | 08:30 ET | [8-K](/filings/0001193125-26-284003.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-284003 | | 2026-06-12 | 16:01 ET | [8-K](/filings/0001193125-26-269326.md) | 5.07 Shareholder vote results | 0001193125-26-269326 | | 2026-06-12 | 08:30 ET | [8-K](/filings/0001193125-26-268548.md) | 8.01 Other events | 0001193125-26-268548 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-100121.md), filed Mar 10, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1000209 - Tickers: MFIN, MBNKO - Exchange: Nasdaq - SIC code: 6199 Finance Services - State of incorporation: DE - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:08 ET. No prices; not investment advice.